Ai-Driven-Biomarker-Discovery

Machine learning over population-scale molecular data that turns weak signals — methylation patterns, mutation signatures, multimodal profiles — into clinical biomarkers. The table carries two vendors with fully sourced dossier ledgers; the wider platform field is named in the note, not padded into the table.